A systematic review of the use of contingent valuation in Alzheimer's disease research

Dementia

Volumn 7, Issue 4, 2008, Pages 461-480

  Oremus, Mark ^a   Tarride, Jean Eric ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b Programme for Appropriate Technology in Health Canada   (Canada)

Author keywords

Systematic review; Willingness to pay

Indexed keywords

EID: 54949125022     PISSN: 14713012     EISSN: 17412684     Source Type: Journal    
DOI: 10.1177/1471301208096630     Document Type: Review

References (33)

1. Aizenberg, D., Weizman, A., & Barak, Y. (2002). Attitudes toward sexuality among nursing home residents. Sexuality and Disability, 20, 185-189.
2. Amella, E.J. (2002). Resistance at mealtimes for persons with dementia. Journal of Nutrition, Health and Aging, 6, 117-122.
3. ANES: American National Election Studies. (2007). National Election Studies study implementation. Ann Arbor, MI: American National Election Studies - Center for Political Studies. Retrieved 23 February 2007 from http://www.electionstudies.org/overview/implement.htm
4. Bayoumi, A.M. (2004). The measurement of contingent valuation for health economics. Pharmacoeconomics, 22, 691-700.
5. Bonato, D., Nocera, S., & Telser, H. (2001). The contingent valuation method in health care: An economic evaluation of Alzheimer's disease. Bern: Volkswirtschaftliches Institut - Universitat Bern.
6. Canadian Study of Health and Aging. (1994). Canadian Study of Health and Aging: Study methods and prevalence of dementia. Canadian Medical Association Journal, 150, 899-913.
7. Chiu, L., Tang, K-Y., Liu, Y-H., Shyu, W-C., & Chang, T-P. (1998). Willingness of families caring for victims of dementia to pay for nursing home care: Results of a pilot study in Taiwan. Journal of Management in Medicine, 12, 349-360.
8. Coben, L.A., Chi, D., Snyder, A.Z., & Storandt, M. (1990). Replication of a study of frequency analysis of the resting awake EEG in mild probable Alzheimer's disease. Electroencephalography and Clinical Neurophysiology, 75, 148-154.
9. Edwards, S.F., & Anderson, G.D. (1987). Overlooked biases in contingent valuation surveys: Some considerations. Land Economics, 63, 168-178.
10. Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A., & Evans, D.A. (2003). Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Archives of Neurology, 60, 1119-1122.
11. Heckman, J.J. (1979). Sample selection bias as a specification error. Econometrica, 47, 153-161.
12. Hirschman, K.B., Joyce, C.M., James, B.D., Xie, S.X., Casarett, D.J., & Karlawish, J.H. (2005). Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication? American Journal of Geriatric Psychiatry, 13, 1014-1021.
13. Jonsson, L., Eriksdotter, J.M., Kilander, L., Soininen, H., Hallikainen, M., Waldemar, G., et al. (2006). Determinants of costs of care for patients with Alzheimer's disease. International Journal of Geriatric Psychiatry, 21, 449-459.
14. Jonsson, L., Jonsson, B., Wimo, A., Whitehouse, P., & Winblad, B. (2000). Second International Pharmacoeconomic Conference on Alzheimer's Disease. Alzheimer Disease and Associated Disorders, 14, 137-140.
15. Karlsson, G., Jonsson, B., Wimo, A., & Winblad, B. (1998). Methodological issues in health economic studies of dementia. In A. Wimo, B. Jonsson, G. Karlsson, & B. Winblad, B. (Eds.), Health economics of dementia (pp. 161-170). Chichester: Wiley.
16. Konig, M., & Wettstein, A. (2002). Caring for relatives with dementia: Willingness-to-pay for a reduction in caregiver's burden. Expert Review of Pharmacoeconomics and Outcomes Research, 2, 535-547.
17. Konig, M., & Zweifel, P. (2004). Willingness-to-pay against dementia: Effects of altruism in between patients and their spouse caregivers (Working Paper No. 0410). Zurich: Socioeconomic Institute - University of Zurich.
18. Lanctot, K.L., Herrmann, N., Yau, K.K., Khan, L.R., Liu, B.A., LouLou, M.M. et al. (2003). Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis. Canadian Medical Association Journal, 169, 557-564.
19. Max, W. (1996). The cost of Alzheimer's disease. Will drug treatment ease the burden? Pharmacoeconomics, 9, 5-10.
20. National Institute for Health and Clinical Excellence. (2006). Dementia: Supporting people with dementia and their carers in health and social care: NICE Clinical Guideline 42. London: National Institute for Health and Clinical Excellence.
21. Nocera, S., Bonato, D., & Telser, H. (2002). The contingency of contingent valuation: How much are people willing to pay against Alzheimer's disease? International Journal of Health Care Finance and Economics, 2, 219-240.
22. Nocera, S., Telser, H., & Bonato, D. (2003). The contingent valuation method in health care. An economic evaluation of Alzheimer's disease. Developments in Health Economics and Public Policy, 8, 1-116.
23. Noji, A., Iida, S., Sato, R., Murashima, S., & Kondo, Y. (1995). A study on health and caregiving status of the elderly over age 75 living in urban Tokyo - social services and caregiving for the bedridden and senile elderly. Seiroka Kango Daigaku Kiyo, 21, 14-24.
24. O'Brien, B. & Gafni, A. (1996). When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making, 16, 288-299.
25. Olsen, J.A. & Smith, R.D. (2001). Theory versus practice: A review of 'willingness-topay' in health and health care. Health Economics, 10, 39-52.
26. Oremus, M., Cosby, J.L., & Wolfson, C. (2005). A hybrid qualitative method for pretesting questionnaires: The example of a questionnaire to caregivers of Alzheimer disease patients. Research in Nursing and Health, 28, 419-430.
27. Ostbye, T., & Crosse, E. (1994). Net economic costs of dementia in Canada. Canadian Medical Association Journal, 151, 1457-1464.
28. Santaguida, P.S., Raina, P., Booker, L., Patterson, C., Baldassarre, F., Cowan, D., et al. (2004). Pharmacological treatment of dementia. Evidence report/technology assessment No. 97. Rockville, MD: Agency for Healthcare Research and Quality.
29. Sonkusare, S.K., Kaul, C.L., & Ramarao, P. (2005). Dementia of Alzheimer's disease and other neurodegenerative disorders - memantine, a new hope. Pharmacological Research, 51, 1-17.
30. van den Berg, B., Brouwer, W., van Exel, J., & Koopmanschap, M. (2005). Economic valuation of informal care: The contingent valuation method applied to informal caregiving. Health Economics, 14, 169-183.
31. Werner, P., Schnaider-Beeri, M., Aharon, J., & Davidson, M. (2002). Family caregivers' willingness to pay for drugs indicated for the treatment of Alzheimer's disease. Dementia, 1, 59-74.
32. Wu, G., Lanctot, K.L., Herrmann, N., Moosa, S., & Oh, P.I. (2003). The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: A willingness-to-pay approach. CNS Drugs, 17, 1045-1057.
33. Zarit, S., Orr, N., & Zarit, J. (1985). The hidden victims of Alzheimer's disease: Families under stress. New York: New York University Press.